*ST Longjin: Announcement on Abnormal Fluctuations in Stock Trading
Kunming Longjin Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.
Kunming Longjin Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.
Kunming Longjin Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.
Kunming Longjin Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.
Kunming Longjin Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.
Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading
Kunming Longjin Pharmaceutical: Response from China Audit Zhonghuan Certified Public Accountants (Special General Partnership) to the inquiry letter on the 2023 annual report of Kunming Longjin Pharmaceutical Co., Ltd.
Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading
Kunming Longjin Pharmaceutical: Notice of Serious Unusual Fluctuations in Stock Trading
Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading
Kunming Longjin Pharmaceutical: 002750*ST Longjin Investor Relations Management Information 20240514
Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading
Kunming Longjin Pharmaceutical: Announcement on participating in the 2023 Investor Online Group Reception Day for Listed Companies in Yunnan
Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading
Kunming Longjin Pharmaceutical: 2024-A004 Special Verification Report on the 2023 Operating Income Deduction Status Table
Kunming Longjin Pharmaceutical: Independent Director's 2023 Debriefing Report (Long Yungang)
Kunming Longjin Pharmaceutical: Independent Director's 2023 Debriefing Report (Sun Handong)
Kunming Longjin Pharmaceutical: Notice on changes in accounting policies
Kunming Longjin Pharmaceutical: Announcement of Board Resolutions
No Data
No Data